BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3445 related articles for article (PubMed ID: 6966167)

  • 1. [Assessment of the immunohistological state of the lymph nodes regional to a tumor].
    Serov AA
    Biull Eksp Biol Med; 1980 Feb; 89(2):196-8. PubMed ID: 6966167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
    Serov AA; Kadagidze ZG
    Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of Ulceration and lymph node metastasis of skin melanomas on the germinal centers of regional lymph nodes].
    Weidner F; Schroll S; Schönberger A; Hornstein OP
    Pathologe; 1982 Jul; 3(4):184-7. PubMed ID: 6981109
    [No Abstract]   [Full Text] [Related]  

  • 4. [Functional activity of the regional lymph nodes in breast cancer patients].
    Loboda VI; Grinevich IuA
    Vopr Onkol; 1983; 29(2):31-6. PubMed ID: 6601329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ki-67 expression in melanoma. A potential method of risk assessment for the patient with a positive sentinel node.
    Pearl RA; Pacifico MD; Richman PI; Stott DJ; Wilson GD; Grobbelaar AO
    J Exp Clin Cancer Res; 2007 Mar; 26(1):109-15. PubMed ID: 17550139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of regional lymph node in vitro antitumor immunoreactivity histology with colorectal carcinoma.
    Pihl E; Nairn RC; Nind AP; Muller HK; Hughes ES; Cuthbertson AM; Rollo AJ
    Cancer Res; 1976 Oct; 36(10):3665-71. PubMed ID: 1085194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional lymphatic immunity in melanoma.
    Grotz TE; Mansfield AS; Jakub JW; Markovic SN
    Melanoma Res; 2012 Feb; 22(1):9-18. PubMed ID: 22082957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The reactivity of the regional lymph nodes and tumor stroma in cervix uteri cancer].
    Raĭchev I; Raĭchev S
    Akush Ginekol (Sofiia); 1993; 32(1):25-8. PubMed ID: 8172342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T and B lymphocytes in lymph nodes and spleen of patients with Hodgkin's disease.
    Berényi E; Sonkoly I; Pálóczi K; Balázs G; Szegedi G
    Neoplasma; 1979; 26(3):307-13. PubMed ID: 394011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T and B lymphocytes of the regional lymph nodes in patients with carcinoma of uterine cervix.
    Ilyin NV; Dexter LI; Bochman YaV
    Neoplasma; 1979; 26(4):423-7. PubMed ID: 392325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic analysis of sentinel lymph nodes in melanoma patients: current and future trends.
    Roberts AA; Cochran AJ
    J Surg Oncol; 2004 Mar; 85(3):152-61. PubMed ID: 14991887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradermal CpG-B activates both plasmacytoid and myeloid dendritic cells in the sentinel lymph node of melanoma patients.
    Molenkamp BG; van Leeuwen PA; Meijer S; Sluijter BJ; Wijnands PG; Baars A; van den Eertwegh AJ; Scheper RJ; de Gruijl TD
    Clin Cancer Res; 2007 May; 13(10):2961-9. PubMed ID: 17504997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients.
    Verdijk P; Aarntzen EH; Lesterhuis WJ; Boullart AC; Kok E; van Rossum MM; Strijk S; Eijckeler F; Bonenkamp JJ; Jacobs JF; Blokx W; Vankrieken JH; Joosten I; Boerman OC; Oyen WJ; Adema G; Punt CJ; Figdor CG; de Vries IJ
    Clin Cancer Res; 2009 Apr; 15(7):2531-40. PubMed ID: 19318472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology of the lymph nodes in patients with malignant melanoma.
    Cochran AJ; Robert ME; Wen DR
    Pathology (Phila); 1994; 2(2):385-400. PubMed ID: 9420909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional lymph node dissections in malignant melanoma.
    Lawton GP; Ariyan S
    Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The morphology of the regional lymph nodes in skin melanoma].
    Frank GA; Iagubova EA
    Vopr Onkol; 1991; 37(11-12):1072-7. PubMed ID: 1669199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic examination of the sentinel lymph node in melanoma.
    Goscin C; Glass LF; Messina JL
    Surg Oncol Clin N Am; 1999 Jul; 8(3):427-34, viii. PubMed ID: 10448687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [T-and B-cell immune response of lymph nodes and immunosuppression correlating with metastatic spread of stomach cancer].
    Bugrov VV; Absaliatova OV; Savkova RF; Kozlova NM
    Vopr Onkol; 2008; 54(2):216-9. PubMed ID: 18522173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in functional immunocompetence of individual tumor-draining lymph nodes in humans.
    Hoon DS; Korn EL; Cochran AJ
    Cancer Res; 1987 Mar; 47(6):1740-4. PubMed ID: 3493068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 173.